ID: ALA4211954

Max Phase: Preclinical

Molecular Formula: C34H32N4O7

Molecular Weight: 608.65

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C)cc(C(=O)N[C@H](Cc2ccc(-c3c(C(=O)O)noc3C)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1

Standard InChI:  InChI=1S/C34H32N4O7/c1-18-12-19(2)14-23(13-18)31(39)36-27(15-21-8-10-22(11-9-21)29-20(3)45-38-30(29)34(43)44)32(40)37-28(33(41)42)16-24-17-35-26-7-5-4-6-25(24)26/h4-14,17,27-28,35H,15-16H2,1-3H3,(H,36,39)(H,37,40)(H,41,42)(H,43,44)/t27-,28+/m1/s1

Standard InChI Key:  CSIHOPHJBWRRMH-IZLXSDGUSA-N

Associated Targets(Human)

Hemoglobin HbA 880 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 608.65Molecular Weight (Monoisotopic): 608.2271AlogP: 4.60#Rotatable Bonds: 11
Polar Surface Area: 174.62Molecular Species: ACIDHBA: 6HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.57CX Basic pKa: CX LogP: 5.25CX LogD: -1.21
Aromatic Rings: 5Heavy Atoms: 45QED Weighted: 0.14Np Likeness Score: -0.50

References

1. Goldstein SR, Liu C, Safo MK, Nakagawa A, Zapol WM, Winkler JD..  (2018)  Design, Synthesis, and Biological Evaluation of Allosteric Effectors That Enhance CO Release from Carboxyhemoglobin.,  (7): [PMID:30034606] [10.1021/acsmedchemlett.8b00166]

Source